GYRE — Gyre Therapeutics, Inc. stock price, charts and financials

QT41Gyre Therapeutics, Inc.

Gyre Therapeutics, Inc. (NASDAQ: GYRE) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
6.72
+0.05+0.75%
OverviewShort InterestFilings
GYREQT41Gyre Therapeutics, Inc.·NASDAQ
6.72+0.75%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 07, 202610-QQuarterly report
Aug 07, 20268-KCurrent report
Aug 04, 20264Statement of changes in beneficial ownership
Aug 04, 20264Statement of changes in beneficial ownership
Aug 04, 20263Initial statement of beneficial ownership
Aug 04, 20263Initial statement of beneficial ownership
Aug 03, 2026EFFECTNotice of effectiveness
Jul 16, 20268-KCurrent report
Jul 15, 20268-K/ACurrent report (amended)
Jul 13, 2026S-3/AShelf registration statement (amended)
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 23, 2026S-3Shelf registration statement
Jun 22, 20264Statement of changes in beneficial ownership
Jun 16, 20268-KCurrent report
Jun 15, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 2026S-8Registration of employee benefit securities
Jun 10, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
#1 / 25 of 193
Page
▼
/ 8